# Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

> **NCT03365141** · NA · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 12 (estimated)

## Conditions studied

- Vitiligo
- Treatment
- Intralesional Injection
- Corticosteroid

## Interventions

- **DRUG:** Triamcinolone acetonide 0.4mg/cc
- **DEVICE:** Phototherapy (NBUVB or excimer laser)
- **DRUG:** Topical tacrolimus

## Key facts

- **NCT ID:** NCT03365141
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-14
- **Primary completion:** 2018-09-15
- **Final completion:** 2018-09-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365141, "Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03365141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*